Some White House officials who work in close proximity to President Donald Trump and Vice President Mike Pence will be offered coronavirus vaccines as soon as this week, while its public distribution is limited to front-line health workers and people in nursing homes and long-term care facilities.
Two people familiar with the matter confirmed that the newly approved vaccine from Pfizer will be made available to those who work in close quarters with the nation's top elected officials. They said the move was meant to prevent more COVID-19 spread in the White House, which has already suffered from several outbreaks of the virus that infected Trump and other top officials.
The two people spoke on condition of anonymity because they were not authorized to discuss the matter publicly. The New York Times first reported the news.
It was not immediately clear how many officials would be offered the vaccine initially and whether Trump or Pence would get it. The move would be consistent with the rollout of rapid testing machines for the coronavirus, which were similarly controlled by the federal government with kits reserved to protect the White House complex and other critical facilities.
According to guidance from the Centers for Disease Control and Prevention, there is not yet enough information to determine whether those who have had COVID-19 should also get the vaccine. Pence has not come down with the virus, and his aides have been discussing when and how he should receive the vaccine as the administration looks to boost public confidence in the shot.
The Pfizer vaccine requires two doses administered three weeks apart, meaning Trump administration officials would receive the final shot just weeks before leaving office.
The Trump administration's vaccination plan could prove to be a boon for his successor, as aides to President-elect Joe Biden have been discussing when and how he should receive the vaccine and working to establish plans to boost virus safeguards in the West Wing to keep the 78-year-old Democrat healthy.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)